solid china order despit covid chao confid beat
metric appetit capital-expenditure instal remain seen
accuray report posit one best
consensu expect total revenu gross net order net incom
strong perform particularli commend like challeng
quarter compani geographi order book china type
type quarter welcom surpris thought pandem
panic might caus busi disappear earli sign recoveri
countri though expect gradual return normal behavior tender
process continu move forward geographi delay
instal quarter push revenu recognit previous
model manag expect longer revenu convers cycl sever quarter
guidanc withdrawn hospit interest abil spend new
capit equip biggest question aray near- mid-term outlook
one silver line may continu move toward hypofraction treatment
pandem clinician look limit patient exposur hospit set
head earn season alreadi cut forecast order
revenu make meaning chang estim like aray
cost-cut effort continu view compound-annual-growth-rate mid-to-long-term
quit achiev see overlook small-cap name plenti
driver power long-term growth investor move past near-term concern
relat capit equip reiter buy pt base month
what ahead earli know hospit approach capit spend
post-pandem mani center face tighter budget previous
reduc near-term order product revenu meaning extend less
pain cut forecast reflect increas age-out
revenu convers cycl lengthen expect servic revenu servic
contract remain stabl taken slight reduct reflect smaller
instal base factor give us confid forecast
conserv includ impress perform earli recoveri china
major growth driver higher percentag aray instal base age
readi replac continu trend toward hypofraction
china revenu convers first round chines type licens
expect begin model revenu
contribut anticip announc second
tranch type licens later quarter remind investor forecast
assum less revenu first-round award
incorpor revenu second round continu see upsid
ro-apm potenti delay crisi astro
industri advoc ask consid delay implement
propos bundl payment scheme januari capit equip
budget shaken perhap addit interest hypofraction think
aray product portfolio well-suit ro-apm whenev put place
valuat pt base month revenu estim risk
discuss
factset btig estim compani
document million except per share amount
develop two main radiat therapi platform cyberknif robot stereotact radiosurgeri stereotact bodi
radiat therapi tomotherapi platform image-guid radiat therapi year lumpi quarter age-
out made tough forecast result recent mgmt commun around age-out cancel
improv help street accur model compani anticip step compani revenu growth profil
result improv investor sentiment
updat disrupt
updat china licens award joint ventur revenu recognit
final implement propos radiat oncolog altern
pandem resolv mid-summ gradual recoveri follow
gross order growth line market growth rate
revenu growth market growth rate
improv gross margin oper margin
rapid resolut pandem faster recoveri afterward
gross order growth rate market
revenu growth rate significantli market
acceler improv gross margin oper margin
pandem last longer slower littl recoveri afterward
gross order growth rate market
revenu growth rate market
declin slower improv gross margin oper margin
radiat oncolog
compani develop sell
system use deliv
system cyberknif tomotherapi
radixact next-gener
acquir tomotherapi inc june
report total sale top forecast product revenu higher
forecast servic revenu came estim gross order
higher estim net order came ahead project
overal gross margin bp model impress servic gross margin far outweigh slight weak
product gross margin oper margin quarter bp forecast driven lower spend across
 sg adjust ebitda well street combin higher
revenu better gross margin low oper spend result ep ten cent higher forecast
previous revis model reflect disrupt pandem potenti macroeconom headwind
could constrain hospit capit equip budget continu feel comfort forecast order revenu
trajectori sinc alreadi model longer revenu convers timelin reduc near-term order volum
maintain gross net order project keep product revenu forecast slightli reduc estim
servic revenu continu see portion revenu rel shelter due servic contract
expect fewer upgrad part revenu segment
margin servic gross margin significantli better anticip due one-tim bonu accrual revers
still line improv increas servic go forward nudg product result
overal higher horizon model reduc spend tweak sg expens lower forecast
total revenu gross order y/i gaap ep
accuray rate buy price target base month revenu estim valuat multipl
conserv incorpor uncertainti around quarter-to-quart volatil order revenu typic small capit
equip compani trade signific discount mid-cap comp group use small-cap due similar growth
believ share deserv see meaning multipl expans compani china busi enabl depend
higher revenu order growth forecast valuat multipl yet account potenti sourc growth
addit licens win china chines joint ventur uptick replac order risk rate includ
includ disrupt revenu recognit award china type licens order volum abil convert order
revenu system fall backlog potenti dilut product delay reimburs capit spend
btig cover compani mention report
appendix analyst certif import disclosur
